RDRaghida Dhayni

Raghida Dhayni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Raghida Dhayni has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Refractory severe aplastic anemia in a child: treatment failure and access barriers in a low-resource setting

    by Zeinab Karaki, Chrystelle Chemaly, Jana Kotaich, Ali Shmeis, Raghida Dhayni

    Introduction and importance: Aplastic anemia (AA) is a rare but potentially fatal hematologic disorder in children, marked by bone marrow failure and pancytopenia. Early diagnosis and access to curative treatment such as hematopoietic stem cell transplantation (HSCT) are crucial. In low-resource settings, limited access to HSCT poses significant challenges. Case presentation: We present a 7-year-old girl with spontaneous ecchymoses and purpura following an upper respiratory infection. Laboratory tests revealed severe pancytopenia, and bone marrow biopsy showed <5% cellularity, consistent with severe AA. Infectious, autoimmune, and malignant causes were excluded. She received immunosuppressive therapy with rabbit anti-thymocyte globulin, cyclosporine A, and corticosteroids but failed to show hematologic recovery. HSCT was not an option due to financial constraints, and she remained transfusion-dependent. Clinical discussion: AA is often immune-mediated, and IST is a standard option when HSCT is unavailable. However, responses vary, particularly in pediatric cases. This case illustrates the limited effectiveness of IST in some patients and highlights how socioeconomic barriers hinder access to definitive treatment, impacting outcomes. Conclusion: This case underscores the urgent need for affordable curative therapies like HSCT in low-income settings. It also emphasizes the variable response to IST and the role of systemic inequities in limiting care for children with life-threatening hematologic diseases.


  • Open Access

    Unusual diagnosis in a Lebanese child with persistent hyper eosinophilia: a case report

    by Mortada Abbass, Lana Joudi, Haidar Khalifeh, Hussein Almasri, Raghida Dhayni

    Introduction and Importance: The differential diagnoses of hypereosinophilia (HE) are diverse and may include parasitic infections, allergic or atopic diseases, and malignancies. The list of differentials for hypereosinophilia is diverse and a comprehensive workup can often be expensive. However, it is essential to identify the underlying cause and treat it rather than treating eosinophilia itself. Case presentation: A 5-year-old male patient was referred to a pediatric hemato-oncologist for concerns of persistent hypereosinophilia, and the absolute eosinophil count (AEC) was greater than 1000 in three recent complete blood count with differentials. The child presented complaining of alternating waxing and waning right and left ankle and knee redness, hotness, pain, and decreased range of motion that occurred every 2 weeks, with associated lack of appetite, fatigue, constipation, and fever reaching 39°C. Clinical discussion: Malignant eosinophilic infiltration of the bone marrow versus a parasitic infection was on top of the differential diagnoses. Presentations of HE suggesting organ system involvement include fever, weight loss, wheezing, cough, dysphagia, vomiting, lack of appetite, diarrhea, arthralgia, and myalgia. Conclusion: Identifying the etiology of persistent hypereosinophilia can be challenging in the pediatric population and can have diverse presentations. The primary focus during initial HE assessment is on evaluating the severity of symptoms and potential organ damage. Major life-threatening diagnoses as malignancies and immune deficiencies must be ruled out first when the AEC is persistently elevated. Parasitic infections should be investigated according to the geographic endemicity.